Patent Assignment
Reel/Frame 067069/0314
Assignment of Assignor's Interest
Recorded: 2024-04-10
Pages: 41
Assignor
MERRIMACK PHARMACEUTICALS, INC.
Executed: 2019-07-12
Assignee
14NER ONCOLOGY, INC.
888 7TH AVE., #30, NEW YORK, NEW YORK, 10106
Covered Property
(1)
Antibodies Against the Ectodomain of ERBB3 and Uses Thereof
Application:
18/630,602 →
Publication:
US 2024/0360243
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 10, 2024
From: SCHOEBERL, BIRGIT; NIELSEN, ULRIK; FELDHAUS, MICHAEL
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 067063/0568 →
Assignment of Assignor's Interest
Apr 10, 2024
From: MURUGANANDAM, ARUMUGAM; BUCKLER, DAVID
To: DYAX CORP.
Reel/Frame 067063/0602 →
Assignment of Assignor's Interest
Apr 10, 2024
From: DYAX CORP.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 067063/0675 →
Change of Name
Apr 10, 2024
From: 14NER ONCOLOGY, INC.
To: ELEVATION ONCOLOGY, INC.
Reel/Frame 067069/0432 →